Privia Health Group (PRVA) to Release Quarterly Earnings on Thursday

Key Points

• Privia will report Q1 2026 results before the market opens on Thursday, May 7 at 8:00 AM ET, with analysts forecasting $0.08 EPS and $559.516 million in revenue.
• In the prior quarter (released Feb. 26) Privia beat expectations, reporting $0.25 EPS versus a $0.04 consensus and revenue of $541.17 million, up 17.4% year‑over‑year.
• Wall Street sentiment is generally positive—the stock has a consensus rating of "Moderate Buy" with an average price target of $31.31 (11 Buys, 3 Holds) and several firms recently raising targets.

Privia Health Group (NASDAQ:PRVA - Get Free Report) is expected to be announcing its Q1 2026 results before the market opens on Thursday, May 7th. Analysts expect the company to announce earnings of $0.08 per share and revenue of $559.5160 million for the quarter. Interested persons are encouraged to explore the company's upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Thursday, May 7, 2026 at 8:00 AM ET.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its quarterly earnings data on Thursday, February 26th. The company reported $0.25 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.21. The business had revenue of $541.17 million during the quarter, compared to the consensus estimate of $516.61 million. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.The firm's revenue was up 17.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.21 earnings per share. On average, analysts expect Privia Health Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Privia Health Group Trading Down 0.6%

NASDAQ PRVA opened at $24.69 on Thursday. The stock has a 50-day simple moving average of $22.53 and a 200 day simple moving average of $23.37. The company has a market capitalization of $3.10 billion, a PE ratio of 145.24, a P/E/G ratio of 1.52 and a beta of 0.87. Privia Health Group has a 12 month low of $18.77 and a 12 month high of $26.51.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on PRVA. Canaccord Genuity Group upped their price objective on Privia Health Group from $34.00 to $35.00 and gave the company a "buy" rating in a report on Friday, February 27th. Truist Financial upped their price objective on Privia Health Group from $31.00 to $33.00 and gave the company a "buy" rating in a report on Monday, March 2nd. Citigroup dropped their price objective on Privia Health Group from $34.00 to $32.00 and set a "buy" rating for the company in a report on Tuesday, March 3rd. Piper Sandler reiterated an "overweight" rating and issued a $36.00 price objective on shares of Privia Health Group in a report on Thursday, February 26th. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of Privia Health Group in a report on Friday, March 27th. Eleven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $31.31.

Insider Transactions at Privia Health Group

In other news, CFO David Mountcastle sold 7,697 shares of the company's stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $25.05, for a total transaction of $192,809.85. Following the completion of the transaction, the chief financial officer directly owned 172,909 shares of the company's stock, valued at $4,331,370.45. This represents a 4.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Matthew Shawn Morris sold 16,550 shares of the company's stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $25.00, for a total value of $413,750.00. Following the transaction, the director directly owned 68,188 shares of the company's stock, valued at $1,704,700. This represents a 19.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 247,757 shares of company stock valued at $5,636,639 over the last three months. Company insiders own 5.70% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Global Retirement Partners LLC boosted its position in shares of Privia Health Group by 579.8% during the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company's stock worth $38,000 after buying an additional 1,351 shares during the period. Canada Pension Plan Investment Board boosted its position in shares of Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company's stock worth $85,000 after buying an additional 1,200 shares during the period. Kestra Advisory Services LLC acquired a new position in shares of Privia Health Group during the fourth quarter worth about $93,000. Raymond James Financial Inc. acquired a new position in shares of Privia Health Group during the second quarter worth about $113,000. Finally, Acadian Asset Management LLC acquired a new position in shares of Privia Health Group during the first quarter worth about $154,000. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Company Profile

Privia Health Group NASDAQ: PRVA is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.